Home » News » FTSE 100 » Croda International completes acquisition of Avanti Polar Lipids
Drug testing lab

Croda International completes acquisition of Avanti Polar Lipids

Croda International Plc (LON:CRDA) has confirmed that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals. 

For further information see the announcement of the acquisition signing dated 6 July 2020. 

Croda International is the speciality chemical company that creates high performance ingredients and technologies relied upon by industries and consumers globally. More at www.croda.com.

Join us on our new LinkedIn page

Follow us on LinkedIn